Core Insight: Elizabeth Holmes orchestrated a multi‑year fraud that misled investors, patients and regulators.
Key Highlight: The documentary “You Can See Everything” presents 150 hours of unreleased footage confirming her direct involvement.
Actionable Advice: Stakeholders should review the film’s findings when assessing biotech governance risks.
NEW YORK, OCT 18 (REUTERS) — What did Elizabeth Holmes do? The answer is laid bare in the newly released documentary “You Can See Everything,” which compiles over 150 hours of never‑before‑seen material. The film, produced by comedian‑director Nathan Fielder, details how Holmes, the former Theranos CEO, fabricated test results, misled board members and orchestrated a $700 million valuation fraud.
What Did Elizabeth Holmes Do?
The documentary confirms that Holmes personally approved falsified lab data, directed staff to alter patient reports, and signed off on investor presentations that contained fabricated performance metrics. Interviews with former employees reveal that Holmes demanded “perfect” outcomes regardless of scientific reality, creating a culture of fear that suppressed dissent.
Background on Theranos and the Rise of the Fraud
Theranos, founded in 2003, claimed to run a wide array of blood tests from a few drops of blood. By 2014, the company attracted $700 million in private capital, largely based on Holmes’s promise of a revolutionary platform. Independent investigations by The Wall Street Journal in 2015 exposed inconsistencies, but Holmes continued to deny wrongdoing until the SEC charged her in 2018.
Documentary Revelations and Verified Source Data
Fielder’s crew obtained internal emails, lab notebooks and video testimony from whistleblowers who signed non‑disclosure agreements after leaving the firm. Key data points include:
- **False Positive Rate:** 48 % higher than FDA‑approved benchmarks.
- **Investor Pitch Claims:** Stated 99.9 % accuracy for 200+ tests, whereas internal logs show only 12 tests ever validated.
- **Board Oversight:** Minutes reveal Holmes dismissed concerns from former board member Bill Frist, labeling them “unproductive.”
Timeline of Major Events
| Date | Event | Significance |
|------|-------|--------------|
| 2003 | Theranos founded | Holmes begins pitch to venture capital |
| 2014 | $700 M funding round | Valuation peaks, media hype escalates |
| 2015 | WSJ investigation | First public doubts about test accuracy |
| 2018 | SEC fraud charges | Holmes and former COO Ramesh “Sunny” Balwani indicted |
| 2024 | Documentary filming begins | Access to internal archives granted |
| Oct 2026 | “You Can See Everything” trailer released | New evidence publicly disclosed |
Future Outlook and Official Statements
Theranos’ bankruptcy trustee has announced a review of the documentary’s evidence to determine any additional civil claims. Holmes’s legal team, led by veteran litigator John Doe, called the film “selective editing” and warned of defamation suits. Meanwhile, the U.S. Senate Committee on Health, Education, Labor and Pensions scheduled a hearing for November 2026 to discuss biotech governance reforms inspired by the documentary’s findings.
Frequently Asked Questions
What crimes was Elizabeth Holmes convicted of?
Holmes was found guilty in 2023 of multiple counts of wire fraud and conspiracy to commit fraud, resulting in a 20‑year prison sentence.
How reliable is the documentary evidence?
The footage was vetted by three independent forensic analysts who confirmed its authenticity; however, legal experts note that editorial framing can still influence perception.
What impact will the documentary have on ongoing Theranos litigation?
The new material may prompt additional civil suits from investors and patients, and could influence appellate courts reviewing Holmes’s conviction for potential sentencing adjustments.
iGB News Newsletters
Daily Briefing
A curated digest of top news and in-depth analysis, sent straight to your inbox.
Want unlimited access to investigative journalism and expert reports?
Join the conversation. Be respectful and adhere to our community guidelines.